Top Markets
Coin of the day
Egetis Therapeutics AB (publ) Egetis Therapeutics AB (publ)

Egetis Therapeutics AB (publ)

EGTX
Peringkat dalam Saham #14552
Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to... Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to progressing drug development, primarily focusing on late-stage projects. The company's core mission involves addressing significant unmet medical needs within the orphan drug sector, concentrating on severe and rare or niche diseases. Its current therapeutic pipeline includes two key drugs undergoing Phase IIb/III clinical trials: Aladote, which is designed to mitigate the risk of acute liver damage associated with acetaminophen/paracetamol poisoning, and Emcitate, intended for the management of MCT8 deficiency, a rare congenital disorder impacting thyroid hormone signaling. Established in 2006, Egetis Therapeutics AB (publ) is headquartered in Stockholm, Sweden, and was previously known as PledPharma AB (publ) until its name change in December 2020.
Harga Saham
$0.88126199
Kapitalisasi Pasar
$409.74M
Perubahan (1 hari)
0.51%
Perubahan (1 tahun)
58.84%
Negara
SE
Perdagangan Egetis Therapeutics AB (publ) (EGTX)

Kategori

Riwayat pemecahan saham untuk Egetis Therapeutics AB (publ) (EGTX)
Saham Egetis Therapeutics AB (publ) (simbol: EGTX) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Sep 01, 2026.
Satu lembar saham EGTX yang dibeli sebelum Sep 01, 2026 sekarang setara dengan 0 lembar saham EGTX.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH